View in EDS HTML Full Text PDF Full Text

Cancer Precision-Prevention trial of Metformin in adults with Li Fraumeni syndrome (MILI) undergoing yearly MRI surveillance: a randomised controlled trial protocol.

Saved in:
Bibliographic Details
Title: Cancer Precision-Prevention trial of Metformin in adults with Li Fraumeni syndrome (MILI) undergoing yearly MRI surveillance: a randomised controlled trial protocol.
Authors: Dixon-Zegeye, Miriam1 (AUTHOR), Shaw, Rachel2 (AUTHOR), Collins, Linda2 (AUTHOR), Perez-Smith, Kendra3 (AUTHOR), Ooms, Alexander4 (AUTHOR), Qiao, Maggie4 (AUTHOR), Pantziarka, Pan5 (AUTHOR), Izatt, Louise6 (AUTHOR), Tischkowitz, Marc7 (AUTHOR), Harrison, Rachel E.8 (AUTHOR), George, Angela9 (AUTHOR), Woodward, Emma R.10,11 (AUTHOR), Lord, Simon1 (AUTHOR), Hawkes, Lara12 (AUTHOR), Evans, D. Gareth10,11 (AUTHOR), Franklin, James13 (AUTHOR), Hanson, Helen14,15 (AUTHOR), Blagden, Sarah P.1,2 (AUTHOR) sarah.blagden@oncology.ox.ac.uk
Source: Trials. 2/2/2024, Vol. 25 Issue 1, p1-14. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17456215
DOI:10.1186/s13063-024-07929-w